215 related articles for article (PubMed ID: 32996785)
21. Permanent alveolar collapse is the predominant mechanism in idiopathic pulmonary fibrosis.
Todd NW; Atamas SP; Luzina IG; Galvin JR
Expert Rev Respir Med; 2015 Aug; 9(4):411-8. PubMed ID: 26165208
[TBL] [Abstract][Full Text] [Related]
22. The Aging Lung and Idiopathic Pulmonary Fibrosis.
Gulati S; Thannickal VJ
Am J Med Sci; 2019 May; 357(5):384-389. PubMed ID: 31010465
[TBL] [Abstract][Full Text] [Related]
23. Dysregulation of club cell biology in idiopathic pulmonary fibrosis.
Zuo WL; Rostami MR; LeBlanc M; Kaner RJ; O'Beirne SL; Mezey JG; Leopold PL; Quast K; Visvanathan S; Fine JS; Thomas MJ; Crystal RG
PLoS One; 2020; 15(9):e0237529. PubMed ID: 32941426
[TBL] [Abstract][Full Text] [Related]
24. Extracellular matrix remodeling in idiopathic pulmonary fibrosis. It is the 'bed' that counts and not 'the sleepers'.
Tomos IP; Tzouvelekis A; Aidinis V; Manali ED; Bouros E; Bouros D; Papiris SA
Expert Rev Respir Med; 2017 Apr; 11(4):299-309. PubMed ID: 28274188
[TBL] [Abstract][Full Text] [Related]
25. β-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix.
Lovgren AK; Kovacs JJ; Xie T; Potts EN; Li Y; Foster WM; Liang J; Meltzer EB; Jiang D; Lefkowitz RJ; Noble PW
Sci Transl Med; 2011 Mar; 3(74):74ra23. PubMed ID: 21411739
[TBL] [Abstract][Full Text] [Related]
26. The quest for the initial lesion in idiopathic pulmonary fibrosis: gene expression differences in IPF fibroblasts.
Eickelberg O; Laurent GJ
Am J Respir Cell Mol Biol; 2010 Jan; 42(1):1-2. PubMed ID: 20026648
[No Abstract] [Full Text] [Related]
27. BDNF/TrkB axis activation promotes epithelial-mesenchymal transition in idiopathic pulmonary fibrosis.
Cherubini E; Mariotta S; Scozzi D; Mancini R; Osman G; D'Ascanio M; Bruno P; Cardillo G; Ricci A
J Transl Med; 2017 Sep; 15(1):196. PubMed ID: 28938915
[TBL] [Abstract][Full Text] [Related]
28. Hsp90 regulation of fibroblast activation in pulmonary fibrosis.
Sontake V; Wang Y; Kasam RK; Sinner D; Reddy GB; Naren AP; McCormack FX; White ES; Jegga AG; Madala SK
JCI Insight; 2017 Feb; 2(4):e91454. PubMed ID: 28239659
[TBL] [Abstract][Full Text] [Related]
29. The effects of collagen-rich extracellular matrix on the intracellular delivery of glycol chitosan nanoparticles in human lung fibroblasts.
Yhee JY; Yoon HY; Kim H; Jeon S; Hergert P; Im J; Panyam J; Kim K; Nho RS
Int J Nanomedicine; 2017; 12():6089-6105. PubMed ID: 28860768
[TBL] [Abstract][Full Text] [Related]
30. Critical role for iron accumulation in the pathogenesis of fibrotic lung disease.
Ali MK; Kim RY; Brown AC; Donovan C; Vanka KS; Mayall JR; Liu G; Pillar AL; Jones-Freeman B; Xenaki D; Borghuis T; Karim R; Pinkerton JW; Aryal R; Heidari M; Martin KL; Burgess JK; Oliver BG; Trinder D; Johnstone DM; Milward EA; Hansbro PM; Horvat JC
J Pathol; 2020 May; 251(1):49-62. PubMed ID: 32083318
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
Epstein Shochet G; Wollin L; Shitrit D
Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis of idiopathic pulmonary fibrosis.
Wolters PJ; Collard HR; Jones KD
Annu Rev Pathol; 2014; 9():157-79. PubMed ID: 24050627
[TBL] [Abstract][Full Text] [Related]
33. Matrices of physiologic stiffness potently inactivate idiopathic pulmonary fibrosis fibroblasts.
Marinković A; Liu F; Tschumperlin DJ
Am J Respir Cell Mol Biol; 2013 Apr; 48(4):422-30. PubMed ID: 23258227
[TBL] [Abstract][Full Text] [Related]
34. Identification and validation of differentially expressed transcripts by RNA-sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis.
Vukmirovic M; Herazo-Maya JD; Blackmon J; Skodric-Trifunovic V; Jovanovic D; Pavlovic S; Stojsic J; Zeljkovic V; Yan X; Homer R; Stefanovic B; Kaminski N
BMC Pulm Med; 2017 Jan; 17(1):15. PubMed ID: 28081703
[TBL] [Abstract][Full Text] [Related]
35. Wilms' tumor 1 drives fibroproliferation and myofibroblast transformation in severe fibrotic lung disease.
Sontake V; Kasam RK; Sinner D; Korfhagen TR; Reddy GB; White ES; Jegga AG; Madala SK
JCI Insight; 2018 Aug; 3(16):. PubMed ID: 30135315
[TBL] [Abstract][Full Text] [Related]
36. Cell-specific expression of runt-related transcription factor 2 contributes to pulmonary fibrosis.
Mümmler C; Burgy O; Hermann S; Mutze K; Günther A; Königshoff M
FASEB J; 2018 Feb; 32(2):703-716. PubMed ID: 28986417
[TBL] [Abstract][Full Text] [Related]
37. Transcription factor YY1 inhibits the expression of THY1 to promote interstitial pulmonary fibrosis by activating the HSF1/miR-214 axis.
Chen L; Yang Y; Peng X; Yan H; Zhang X; Yin L; Yu H
Aging (Albany NY); 2020 May; 12(9):8339-8351. PubMed ID: 32396525
[TBL] [Abstract][Full Text] [Related]
38. Epithelial⁻Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis.
Salton F; Volpe MC; Confalonieri M
Medicina (Kaunas); 2019 Mar; 55(4):. PubMed ID: 30925805
[TBL] [Abstract][Full Text] [Related]
39. Fibrotic extracellular matrix activates a profibrotic positive feedback loop.
Parker MW; Rossi D; Peterson M; Smith K; Sikström K; White ES; Connett JE; Henke CA; Larsson O; Bitterman PB
J Clin Invest; 2014 Apr; 124(4):1622-35. PubMed ID: 24590289
[TBL] [Abstract][Full Text] [Related]
40. The Potential Effects of Curcumin on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)-Approaching with Next-Generation Sequencing and Bioinformatics.
Chang WA; Chen CM; Sheu CC; Liao SH; Hsu YL; Tsai MJ; Kuo PL
Molecules; 2020 Nov; 25(22):. PubMed ID: 33233354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
